Clinical Trial Update: An Open-Label Trial of Losartan Potassium in Participants With Eosinophilic Esophagitis (EoE) [Phase 2]

View source ↗

Summary

Phase 2 open-label trial of losartan potassium in participants with eosinophilic esophagitis has completed and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Esophagitis

Drugs mentioned

• Losartan Potassium (Losartan potassium)

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Eosinophilic Esophagitis | Phase 2 | Status: COMPLETED | Results posted: 2020-08-10